| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 49.462 | 48.345 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 49.462 | 48.345 | 109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 5.225 | 4.813 | 2.637 | 174 | 111 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 44.237 | 43.532 | -2.528 | -174 | -111 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 42.753 | 42.082 | -2.531 | -174 | -111 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oxigen Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.512 | 2.338 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 74.527 | 110.566 | 1.050 | 857 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 74.527 | 110.566 | 1.050 | 857 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | 79.890 | 42.135 | -2.479 | -2.607 | -2.668 | -2.617 | -2.559 | -2.567 | -2.559 | -2.545 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 148 | 70.769 | 3.529 | 3.464 | 2.668 | 2.617 | 2.559 | 2.567 | 2.559 | 2.545 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Oxigen Intermed S.r.l.